$132,964,607

Ongoing support for Tulane National Primate Research Center, a long-running NIH-funded facility conducting biomedical research using non-human primates.

Primate research remains critical for vaccine development, infectious disease modeling, and translational studies that cannot be replicated in vitro or in other animal models.

Sustained funding supports specialized veterinary services, primate breeding/sourcing networks, and laboratory equipment suppliers serving the research facility.

U.S. primate research infrastructure is a strategic asset; China has expanded primate research capacity and competes for biomedical discoveries in vaccine and infectious disease domains.